Shah AY - Search Results

1

Communication principles and practices for making shared decisions about renal replacement therapy: a review of the literature.

Saeed F, Shah AY, Allen RJ, Epstein RM, Fiscella KA. Saeed F, et al. Among authors: shah ay. Curr Opin Nephrol Hypertens. 2021 Sep 1;30(5):507-515. doi: 10.1097/MNH.0000000000000731. Curr Opin Nephrol Hypertens. 2021. PMID: 34148978 Free PMC article. Review.

2

Awareness and knowledge regarding rotavirus disease and vaccine among healthcare providers in tertiary care settings.

Shah AY, Ali Inam SH, Jamal S, Haider SJ, Iqbal M, Jamil H. Shah AY, et al. J Pak Med Assoc. 2021 May;71(5):1479-1482. doi: 10.5455/JPMA.1150. J Pak Med Assoc. 2021. PMID: 34091639 Free article.

3

Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial.

Powles T, Burotto M, Escudier B, Apolo AB, Bourlon MT, Shah AY, Suárez C, Porta C, Barrios CH, Richardet M, Gurney H, Kessler ER, Tomita Y, Bedke J, George S, Scheffold C, Wang P, Fedorov V, Motzer RJ, Choueiri TK. Powles T, et al. Among authors: shah ay. ESMO Open. 2024 Apr 19;9(5):102994. doi: 10.1016/j.esmoop.2024.102994. Online ahead of print. ESMO Open. 2024. PMID: 38642472 Free PMC article.

4

Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.

Campbell MT, Balderrama-Brondani V, Jimenez C, Tamsen G, Marcal LP, Varghese J, Shah AY, Long JP, Zhang M, Ochieng J, Haymaker C, Habra MA. Campbell MT, et al. Among authors: shah ay. Lancet Oncol. 2024 May;25(5):649-657. doi: 10.1016/S1470-2045(24)00095-0. Epub 2024 Apr 9. Lancet Oncol. 2024. PMID: 38608694 Clinical Trial.

5

Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma.

Matin SF, Adibi M, Shah AY, Alhalabi O, Corn P, Guo C, Amirtharaj R, Xiao L, Lange S, Duose DY, Wang S, Pal S, Campbell MT. Matin SF, et al. Among authors: shah ay. J Urol. 2024 Apr 10:101097JU0000000000003928. doi: 10.1097/JU.0000000000003928. Online ahead of print. J Urol. 2024. PMID: 38573872

6

Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma.

Johns AC, Campbell MT, Gao M, Hahn AW, Lim Z, Wang E, Gao J, Shah AY, Msaouel P, Tannir NM. Johns AC, et al. Among authors: shah ay. Oncologist. 2024 Mar 13:oyae037. doi: 10.1093/oncolo/oyae037. Online ahead of print. Oncologist. 2024. PMID: 38478923 Free article.

7

Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events.

Fayle SE, Palaskas NL, Siddiqui BA, McQuade JL, Lin JS, Subudhi SK, Patel AB, Jenq RR, Shah AY, Spelman AR, Sun M, Marble BH, Wang Y. Fayle SE, et al. Among authors: shah ay. J Natl Compr Canc Netw. 2024 Jan 8:1-8. doi: 10.6004/jnccn.2023.7119. Online ahead of print. J Natl Compr Canc Netw. 2024. PMID: 38190801

8

Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.

Hahn AW, Surasi DS, Viscuse PV, Bathala TK, Wiele AJ, Campbell MT, Zurita AJ, Shah AY, Jonasch E, Gao J, Goswami S, Alhalabi O, Rao P, Sircar K, Tannir NM, Msaouel P. Hahn AW, et al. Among authors: shah ay. Oncologist. 2024 May 3;29(5):392-399. doi: 10.1093/oncolo/oyad302. Oncologist. 2024. PMID: 38035767 Free PMC article.

9

Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry.

Balderrama-Brondani V, Griffin AM, Owen TJ, Merriman KW, Chahla BB, Varghese J, Jimenez C, Waguespack SG, Graham PH, Perrier ND, Fisher SB, Karam JA, Shah AY, Campbell M, Hassan MM, Habra MA. Balderrama-Brondani V, et al. Among authors: shah ay. Endocr Pract. 2024 Jan;30(1):25-30. doi: 10.1016/j.eprac.2023.10.004. Epub 2023 Oct 18. Endocr Pract. 2024. PMID: 37858722

10

Controlled synthesis of photoresponsive bismuthinite (Bi₂S₃) nanostructures mediated through a new 1D bismuth-pyrimidylthiolate coordination polymer as a molecular precursor.

Kulkarni AY, Karmakar G, Shah AY, Nigam S, Kumbhare G, Tyagi A, Butcher RJ, Chauhan RS, Kumar NN. Kulkarni AY, et al. Among authors: shah ay. Dalton Trans. 2023 Nov 14;52(44):16224-16234. doi: 10.1039/d3dt02143b. Dalton Trans. 2023. PMID: 37853758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page